The U.S. is gearing up for another wave of COVID-19 infections in the fall and winter following a flurry of activity this week that included putting billions of dollars toward Read more
Tag: Novavax Inc.
Novavax is part of the FDA’s COVID-19 booster debate, but its vaccine still hasn’t been authorized
Novavax’s NVAX, +1.04% COVID-19 vaccine candidate played a front-and-center role during this week’s debate about how best to update the COVID-19 boosters to better protect against omicron. The catch? The Read more
FDA advisers say the U.S. needs updated COVID-19 boosters to fight omicron
The U.S. should pursue a COVID-19 booster strategy that focuses on developing new shots that better protect against omicron and its subvariants, according to a recommendation from a Food and Read more